Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04129086 · ClinicalTrials.gov registry record · Phase 4
Ketamine for Acute Pain Management After Trauma
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 305
- Enrollment target
NCT04129086 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 305 participants.
The verdict
NCT04129086, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 305 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness of Ketamine drip along with usual care and usual care alone on trauma patients and to longitudinally quantify the pain experience of patients during hospitalization.
Interventions
- DRUG Usual Care
- DRUG Ketamine plus usual care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 305 participants |
| Start Date | 2020-07-01 |
| Est. Completion | 2022-09-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04129086
The ClinicalTrials.gov registry entry for NCT04129086 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 305 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT04129086 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04129086 about?
NCT04129086 is a clinical study titled "Ketamine for Acute Pain Management After Trauma". The purpose of this study is to compare the effectiveness of Ketamine drip along with usual care and usual care alone on trauma patients and to longitudinally quantify the pain experience of patients during hospitalization.
What is the current status of trial NCT04129086?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 305 participants. The study started on 2020-07-01. Estimated completion is 2022-09-30.
What interventions are being tested in trial NCT04129086?
The interventions under investigation include: Usual Care (DRUG), Ketamine plus usual care (DRUG).
Who is sponsoring clinical trial NCT04129086?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.